HomeNTRA • NASDAQ
add
Natera Inc
Nakaraang pagsara
$154.48
Sakop ng araw
$151.29 - $155.50
Sakop ng taon
$90.88 - $183.00
Market cap
20.79B USD
Average na Volume
1.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 476.06M | 53.02% |
Gastos sa pagpapatakbo | 364.38M | 49.09% |
Net na kita | -53.77M | 31.09% |
Net profit margin | -11.29 | 54.98% |
Kita sa bawat share | -0.41 | 35.94% |
EBITDA | -60.45M | 24.46% |
Aktuwal na % ng binabayarang buwis | 2.46% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 968.28M | 10.16% |
Kabuuang asset | 1.66B | 15.19% |
Kabuuang sagutin | 465.32M | -31.20% |
Kabuuang equity | 1.20B | — |
Natitirang share | 135.19M | — |
Presyo para makapag-book | 17.15 | — |
Return on assets | -9.95% | — |
Return on capital | -11.83% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -53.77M | 31.09% |
Cash mula sa mga operasyon | 52.89M | 191.81% |
Cash mula sa pag-invest | -11.12M | -146.05% |
Cash mula sa financing | 10.97M | 60.32% |
Net change in cash | 52.74M | 298.17% |
Malayang cash flow | 56.64M | 243.63% |
Tungkol
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Itinatag
Ene 1, 2004
Headquarters
Website
Mga Empleyado
4,429
